CIK 0001177648 · Non-accelerated filer<br>Smaller reporting company
ENANTA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ENTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Entity type
- operating
- EIN
- 043205099
- Phone
- 617 607 0800
- Business address
- 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-05 | Kieffer Tara Lynn Sr. VP, New Prod. Strat. & Dev | Sale | −2,125 | $9.63 | $20K | 37,260 |
| 2023-12-05 | Gardiner Nathaniel S. Sr. VP & General Counsel | Sale | −2,412 | $9.63 | $23K | 68,154 |
| 2023-12-05 | Rottinghaus Scott T. Sr. VP & CMO | Sale | −534 | $9.63 | $5K | 26,466 |
| 2023-12-05 | Or Yat Sun Sr. VP, R&D & CSO | Sale | −2,412 | $9.63 | $23K | 370,695 |
| 2023-12-05 | MELLETT PAUL J Sr. VP, Finance & Admin. & CFO | Sale | −2,412 | $9.63 | $23K | 93,549 |
| 2023-12-05 | Luly Jay R. President and CEO | Sale | −7,230 | $9.63 | $70K | 806,793 |
| 2023-12-01 | Luu Brendan Sr. VP, Business Dev. | Shares withheld for taxes | −753 | $9.49 | $7K | 38,861 |
| 2023-12-01 | Kieffer Tara Lynn Sr. VP, New Prod. Strat. & Dev | Shares withheld for taxes | −753 | $9.49 | $7K | 39,385 |
| 2023-12-01 | Gardiner Nathaniel S. Sr. VP & General Counsel | Shares withheld for taxes | −1,595 | $9.49 | $15K | 70,566 |
| 2023-12-01 | Or Yat Sun Sr. VP, R&D & CSO | Shares withheld for taxes | −1,595 | $9.49 | $15K | 373,107 |
| 2023-12-01 | MELLETT PAUL J Sr. VP, Finance & Admin. & CFO | Shares withheld for taxes | −1,595 | $9.49 | $15K | 95,961 |
| 2023-12-01 | Luly Jay R. President and CEO | Shares withheld for taxes | −5,787 | $9.49 | $55K | 814,023 |
| 2023-11-22 | Luu Brendan Sr. VP, Business Dev. | Grant or award · Stock Option (right to buy) | +83,000 | 83,000 | ||
| 2023-11-22 | Kieffer Tara Lynn Sr. VP, New Prod. Strat. & Dev | Grant or award · Stock Option (right to buy) | +83,000 | 83,000 | ||
| 2023-08-08 | Rottinghaus Scott T. Chief Medical Officer | Shares withheld for taxes | −1,467 | $17.23 | $25K | 25,533 |
Page 7 of 7 · 135 trades